Instituto Português Oncologia Francisco Gentil do Porto

Porto 4200-072

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, HER-2 Positive Breast Cancer, Metastatic Neoplasm, Renal Cell Carcinoma

Studies at this site

• Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma — Completed
• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Completed
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed